Marizyme, Inc. announced a private placement for gross proceeds of $265,216 on April 18, 2023. The company issued convertible preferred stock and option, warrant or other right to acquire another security in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 USD | +3.77% | +3.77% | -45.05% |
02-06 | Marizyme, Inc. Announces Resignation of Julie Kampf from the Board of Directors | CI |
2023 | Marizyme, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-45.05% | 2.57M | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- GBSX Stock
- News Marizyme, Inc.
- Marizyme, Inc. announced that it expects to receive $0.265216 million in funding